Literature DB >> 23144441

Reduction in intraoperative bacterial contamination of peripheral intravenous tubing through the use of a passive catheter care system.

Randy W Loftus1, Bryan S Brindeiro, David P Kispert, Hetal M Patel, Matthew D Koff, Jens T Jensen, Thomas M Dodds, Mark P Yeager, Kathryn L Ruoff, John D Gallagher, Michael L Beach, Jeremiah R Brown.   

Abstract

BACKGROUND: Bacterial contamination of intravascular devices has been associated with increased morbidity and mortality in various hospital settings, including the perioperative environment. Catheter hub disinfection has been shown in an ex vivo model to attenuate intraoperative injection of bacterial organisms originating from the anesthesia provider's hands, providing the impetus for improvement in intraoperative disinfection techniques and compliance. In the current study, we investigated the clinical effectiveness of a new, passive catheter care station in reducing the incidence of bacterial contamination of open lumen patient IV stopcock sets. The secondary aim was to evaluate the impact of this novel intervention on the combined incidence of 30-day postoperative infections and IV catheter-associated phlebitis.
METHODS: Five hundred ninety-four operating room environments were randomized by a computer-generated list to receive either a novel catheter care bundle (HubScrub and DOCit) or standard caps in conjunction with a sterile, conventional open lumen 3-way stopcock set (24 inch with 3-gang 4-way and T-Connector). Patients underwent general anesthesia according to usual practice and were followed prospectively for 30 postoperative days to identify the development of health care-associated infections (HCAIs) and/or phlebitis. The primary outcome was intraoperative bacterial contamination of the primary stopcock set used by the anesthesia provider(s). The secondary outcome was the combined incidence of 30-day postoperative infections and phlebitis.
RESULTS: Five hundred seventy-two operating rooms were included in the final analysis. Study groups were comparable with no significant differences in patient, provider, anesthetic, or procedural characteristics. The catheter care station reduced the incidence of primary stopcock lumen contamination compared with standard caps (odds ratio [OR] 0.79, 95% confidence interval [CI] 0.63-0.98, P = 0.034) and was associated with a reduction in the combined incidence of HCAIs and IV catheter-associated phlebitis with and without adjustment for patient and procedural covariates (OR(adjusted) 0.589, 95% CI 0.353-0.984, P = 0.040). The risk-adjusted number needed to treat to eliminate 1 case of lumen contamination was 9 (95% CI 3.4-13.5) patients, whereas the risk-adjusted number needed to treat to eliminate 1 case of HCAI/catheter-associated phlebitis was 17 (95% CI 11.8-17.9) patients.
CONCLUSION: Intraoperative use of a passive catheter care station significantly reduced open lumen bacterial contamination and the combined incidence of 30-day postoperative infections and phlebitis.

Entities:  

Mesh:

Year:  2012        PMID: 23144441     DOI: 10.1213/ANE.0b013e31826d2aa4

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  9 in total

Review 1.  The effects of care bundles on patient outcomes: a systematic review and meta-analysis.

Authors:  Jacqueline F Lavallée; Trish A Gray; Jo Dumville; Wanda Russell; Nicky Cullum
Journal:  Implement Sci       Date:  2017-11-29       Impact factor: 7.327

2.  Sample sizes for surveillance of S. aureus transmission to monitor effectiveness and provide feedback on intraoperative infection control including for COVID-19.

Authors:  Franklin Dexter; Johannes Ledolter; Russell T Wall; Subhradeep Datta; Randy W Loftus
Journal:  Perioper Care Oper Room Manag       Date:  2020-05-21

3.  The effect of implementing an aseptic practice bundle for anaesthetists to reduce postoperative infections, the Anaesthetists Be Cleaner (ABC) study: protocol for a stepped wedge, cluster randomised, multi-site trial.

Authors:  Alan F Merry; Derryn A Gargiulo; Ian Bissett; David Cumin; Kerry English; Christopher Frampton; Richard Hamblin; Jacqueline Hannam; Matthew Moore; Papaarangi Reid; Sally Roberts; Elsa Taylor; Simon J Mitchell
Journal:  Trials       Date:  2019-06-10       Impact factor: 2.279

4.  Anesthesia Workspace Cleanliness and Safety: Implementation of a Novel Syringe Bracket Using 3D Printing Techniques.

Authors:  Dustin R Long; Allison Doney; Devan L Bartels; Crystal E Tan; Puneet K Sayal; Thomas A Anderson; Aalok V Agarwala
Journal:  Anesthesiol Res Pract       Date:  2019-07-01

5.  Measures for prevention of infection transmission in the operating room: Paradigm shift after COVID-19.

Authors:  J Mata Estévez
Journal:  Rev Esp Anestesiol Reanim (Engl Ed)       Date:  2020-11-20

6.  Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update.

Authors:  Niccolò Buetti; Jonas Marschall; Marci Drees; Mohamad G Fakih; Lynn Hadaway; Lisa L Maragakis; Elizabeth Monsees; Shannon Novosad; Naomi P O'Grady; Mark E Rupp; Joshua Wolf; Deborah Yokoe; Leonard A Mermel
Journal:  Infect Control Hosp Epidemiol       Date:  2022-04-19       Impact factor: 6.520

7.  Microbiological testing of devices used in maintaining peripheral venous catheters.

Authors:  Fernanda de Paula Rossini; Denise de Andrade; Lissandra Chaves de Sousa Santos; Adriano Menis Ferreira; Caroline Tieppo; Evandro Watanabe
Journal:  Rev Lat Am Enfermagem       Date:  2017-05-15

8.  Strategies for daily operating room management of ambulatory surgery centers following resolution of the acute phase of the COVID-19 pandemic.

Authors:  Franklin Dexter; Mohamed Elhakim; Randy W Loftus; Melinda S Seering; Richard H Epstein
Journal:  J Clin Anesth       Date:  2020-04-29       Impact factor: 9.452

Review 9.  Perioperative COVID-19 Defense: An Evidence-Based Approach for Optimization of Infection Control and Operating Room Management.

Authors:  Franklin Dexter; Michelle C Parra; Jeremiah R Brown; Randy W Loftus
Journal:  Anesth Analg       Date:  2020-07       Impact factor: 6.627

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.